HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Periodic production of antiplatelet autoantibody directed against GPIIIa in cyclic thrombocytopenia.

Abstract
We report here a female patient with cyclic thrombocytopenia associated with antiplatelet autoantibodies. There was an inverse relationship between the level of platelet-associated IgG and platelet count. Bone marrow megakaryocytes were normal in number even during the thrombocytopenia. The binding of monoclonal antibodies (mAbs) against glycoprotein (GP) IIb/IIIa to patient platelets was significantly inhibited in the thrombocytopenic phase, while these mAbs normally bound to patient platelets obtained during the normal platelet count. Western blotting and mAb-specific immobilization of platelet antigens showed that both plasma autoantibody and the eluted IgG from the patient platelets bound to GPIIIa. These results suggest that the periodic production of antiplatelet autoantibody against GPIIIa caused cyclic destruction of platelets in this patient.
AuthorsM Yanabu, S Nomura, T Fukuroi, T Kawakatsu, H Kido, K Yamaguchi, M Suzuki, T Kokawa, K Yasunaga
JournalActa haematologica (Acta Haematol) Vol. 89 Issue 3 Pg. 155-9 ( 1993) ISSN: 0001-5792 [Print] Switzerland
PMID8362605 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Autoantibodies
  • Immunoglobulin G
  • Platelet Membrane Glycoproteins
Topics
  • Adult
  • Antibodies, Monoclonal
  • Autoantibodies (biosynthesis, blood)
  • Blood Platelets (immunology)
  • Blotting, Western
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Humans
  • Immunoglobulin G (blood)
  • Periodicity
  • Platelet Count
  • Platelet Membrane Glycoproteins (immunology)
  • Thrombocytopenia (blood, etiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: